Peptide-Based Therapies for Obesity in American Males: Efficacy, Safety, and Long-Term Outcomes
Reading Time: 3 minutes Introduction Obesity remains a significant public health challenge in the United States, particularly among American males, where it is associated with increased risks of chronic diseases such as type 2 diabetes, cardiovascular disease, and certain cancers. Recent advances in medical science have led to the development of peptide-based treatments that target specific pathways involved in appetite regulation and energy metabolism. This article provides a systematic review of the efficacy, safety, and long-term outcomes of peptide-based therapies for obesity management in American males. Efficacy of Peptide-Based Treatments Peptide-based treatments, such as glucagon-like peptide-1 (GLP-1) receptor agonists and peptide YY (PYY) analogs,...


